PharmiWeb.com - Global Pharma News & Resources
20-Dec-2018

5-HT1D Agonist Pipeline Insight, 2018 Report - ResearchAndMarkets.com

The "5-HT1D Agonist -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

5-HT1D Agonist - Pipeline Insight, 2018 report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1D Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for 5-HT1D Agonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Introduction

2. Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products

4. Comparative Analysis

5. Pipeline Products in Clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

6. Pipeline Products in Non-clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment: Active Products

  • Pipeline Assessment by Route of Administration
  • Pipeline Assessment by Stage and Route of Administration
  • Pipeline Assessment by Molecule Type
  • Pipeline Assessment by Stage and Molecule Type

8. Inactive Pipeline Products

  • Product Description
  • Research and Development
  • Product Development Activities
  • Reason for dormancy/discontinuation

Companies Mentioned

  • Merck & Co
  • Pfizer
  • Dr Reddys Laboratories
  • NuPathe
  • Civitas Therapeutics
  • NovaDel Pharma
  • OptiNose AS
  • GlaxoSmithKline
  • Burroughs Wellcome

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/56xxwm/5ht1d_agonist?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181220005747/en/

Editor Details

Last Updated: 20-Dec-2018